05/03/2026
BREAKTHROUGH: New Immunotherapy Aims to Activate the Body’s Natural Killer Cells
A new cancer treatment called ANKTIVA, introduced by Patrick Soon-Shiong, is drawing attention for its innovative approach to immunotherapy.
Instead of directly attacking tumors like traditional chemotherapy, ANKTIVA works by stimulating the body’s natural killer (NK) cells—a key part of the immune system responsible for identifying and destroying abnormal or cancerous cells.
By boosting the activity of these immune defenders, researchers hope to improve the body’s ability to recognize and eliminate malignant cells with greater precision, potentially reducing systemic side effects.
ANKTIVA is entering a rapidly evolving field of immune-based cancer therapies, where scientists aim to strengthen the body’s natural defense systems to fight disease more effectively.
Ongoing clinical trials and regulatory review will help determine how widely this treatment can be used across different types of cancer.
Reference: New top
------------------
FUTURE BIOMED CLINIC AND LAB
Bangkok Rejuvenation Center
""A HEALTHIER, HAPPIER AND YOUNGER YOU""
📱+84937534545 (Vietnam) | +66961143399 (Thailand)
🌐 https://fbiomed.com/
📍Sukhumvit, Bangkok, Thailand